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Reduction of esophageal injury by contrast visualization of the esophagus
during radiofrequency ablation for atrial ﬁbrillation
Yang Ye, Chenyang Jiang
Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
OBJECTIVES Ablation along the posterior wall of left atrium can
result in atrioesophageal ﬁstula due to thermal injury to the esoph-
agus. The purpose of our study was to investigate whether contrast
visualization of the esophagus reduces collateral injury during atrial
ﬁbrillation (AF) ablation.
METHODS 78 patients with paroxysmal AF underwent circumferen-
tial pulmonary vein isolation (PVI) guided by ingested contrast me-
dium of esophagus with follow-up endoscopy within 24 hours. Cine
imaging of the esophagus was performed at the beginning of ablation,
after adjacentipsilateral PVI, and at the end of the procedure. Posi-
tions were measured by ﬂuoroscopic images. The ablation lesion set
was modiﬁed to minimize overlap with the esophagus in the contrast-
guided group and a single ﬁnal ingestion was performed at the end of
the procedure for the control group. Esophageal damage was assessed
by esophageoscopy within 24 hours.
RESULTS The incidence of esophageal damage was 20.5% (8/39) in
control group and was 5.1% (2/39) in visualization group (p <0.05). The
ablation lesion set crossed over the esophagus in 46.2% of patients in the
control group whereas the ablation line could not be altered away from
the esophagus in 15.4% of patients in visualization group (p<0.01). Only
1.9% (1/54) patients in non-crossed group had esophagus damage, but
37.5% (9/24) patients in crossed group had lesions (p <0.01).
CONCLUSIONS Esophageal contrast-guided PVI can reduce esopha-
geal damage in patients referred for AF ablation.
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Active-ﬁxation Atrial Pacing Leads Following Amputation of Right Atrial
Appendage: Long-term, Single-centre Study
Dong Huang, Qingyong Zhang, Yesheng Pan, Mingya Liu, Meng Wei,
Jingbo Li
Shanghai Sixth People’s Hospital Afﬁliated to Jiaotong University,
Shanghai Jiaotong University School of Medicine
OBJECTIVES To investigate the long-term feasibility and stability of
active-ﬁxation pacing leads following amputation of right atrial
appendage (RAA).
METHODS Active-ﬁxation leads were used in 85 consecutive sick sinus
syndrome or high-grade atrioventricular block patients with (Group 1,
n¼22) or without (Group 2, n¼63) amputation of RAA underwent implan-
tationofdual-chamberpacemakers.X-ray, threshold, sensing, impedance,
average implantation exposure time and lead-related complications
were evaluated at implantation (D0), and at 1, 3, 6, 12, 24, and 36 months.
RESULTS All leads were successfully implanted. Over long-term
follow-up, all leads remained stable as evidenced by X-ray. Initial
sensing of both groups were equal and stable in both groups.
Impedance declined slightly (P>0.05) from D0 to M1 and remained
stable thereafter. Threshold of atrial pacing lead decreased signiﬁ-
cantly during the ﬁrst 3 months and remained stable thereafter while
the threshold of ventricular pacing lead remained stable throughout
the whole study, with neither of them showing signiﬁcant difference
between groups. No lead-related complications were found.
CONCLUSIONS Active-ﬁxation atrial pacing leads can be successfully
ﬁxed to the bottom of the residual appendage in patients undergone
amputation of RAAwith overall good and stable long-term parameters.
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Does Anemia Cause QT Prolongation in Patients with Hematologic
Disorders?
Yudong Fei,1 William Surkis,2 Li Zhang,2 Yigang Li1
1Department of Cardiology, Xinhua Hospital, Shanghai JiaoTong
University, Shanghai, China; 2Lankenau Medical Center & Lankenau
Institute for Medical Research, Sydney Kimmel Medical College at
Thomas Jefferson University, Philadelphia, PA, USA
OBJECTIVES The prolongation of QT interval is associated with car-
diovascular mortality and morbidity. QT prolongation is common in
patientswith sickle cell disease and it is reported that a lowerhemoglobin
level correlates with a longer QT interval in these patients. Suchcorrelation, however, has not been determined in patients with other
types of hematologic disorders. This study aims to investigate whether
there is an association between reduced hemoglobin and QT interval in
patients with anemia caused by disorders other than sickle cell disease.
METHODS ECGs of patients with hemoglobin (Hgb) <10 g/dl enrolled
from our Hematology Department were evaluated for the presence of
QT prolongation using Bazett’s formula for heart rate corrected QTc. In
subjects with QRS duration >120 ms, JT index (JTI¼JT(HRþ100)/518)
was applied to estimate their repolarization time. It is reported that JTI
> 112 is an indication of delayed ventricular repolarization. Among
study subjects (Hgb 8.01.6 g/dl, range 1.9-9.9 g/dl), moderate anemia
(Hgb 6-9 g/dl) accounted for 56% and severe anemia (Hgb <6 g/dl) for
12%. Anemia was related to leukemia in 40% (121/300), lymphoma in
28%, myelodysplastic syndrome in 9%, multiple myeloma in 8%,
aplastic anemia in 4%, and the remainder with other types of hemato-
logic disorders. None of the patients had left ventricular hypertrophy,
electrolyte abnormalities, or were receiving QT-prolonging drugs.
RESULTS The average QTc in 300 patients with hematologic disorders
was 414  23 ms. There were 21 patients with a QTc >440 ms.
Nevertheless, 33% (7/21) of them had a prolonged depolarization time
(QRS duration 120 ms) including complete left (4), right bundle
branch blocks (1) and right ventricular pacing (2), respectively. Their
JT index were all <112 ms, suggesting the repolarization time was
normal. Therefore, only 5% (14/300) of all anemic patients had a
borderline to moderate QTc prolongation (461 13 ms, range: 441-479
ms) and none of them experienced syncope, cardiac arrest, or sudden
death. Linear regression analysis showed no signiﬁcant correlation
between reduced hemoglobin level and QT prolongation (P¼0.587).
To determine whether the severity of anemia affects QTc interval,
study subjects were then divided into three groups separated by Hgb
levels. The result of ANOVA showed no statistical signiﬁcance be-
tween the lengths of QTc in the 3 groups (P¼0.656).
CONCLUSIONS In anemic patientswithout left ventricular hypertrophy,
electrolyte imbalances, use of QT-prolonging drugs, or any other identi-
ﬁable causes of ALQTS, the QT interval is normal inmost cases, and there
is no signiﬁcant correlation between hemoglobin level and QT interval.
GW26-e1027
Electric Pulse Current Stimulation promotes mShox2 Genetically Modiﬁed
Canine Mesenchymal Stem Cells generating If current
Yuanyuan Feng, Shouming Luo, Pan Yang, Zhiyuan Song
Southwest Hospital
OBJECTIVES To investigate whether mShox2 genetically modiﬁed
canine mesenchymal stem cells (cMSCs) induced by electric pulse
current stimulation (EPCS) could generate If current in vitro.
METHODS The cMSCs were transfected with pLentis-mShox2-RFP or
pLentis-RFP. After EPCS induction, these cells were designed into four
groups: the RFP transfected cMSCs (Group A as control), the RFP trans-
fected cMSCs induced by EPCS (Group B), the mShox2-RFP transfected
cMSCs (Group C), and the mShox2-RFP transfected cMSCs induced by
EPCS (Group D). We examined the kinetic characteristics of generated
inward current by patch-clamp.We then evaluated Nkx2.5, Tbx3, HCN4,
Cx43 and Cx45 expression using qRT-PCR and Western blotting.
RESULTS The time-and voltage-dependent inward current recorded in
group C was conﬁrmed as the If current. After EPCS induction, the detec-
tion rate of this If current was increased (Group D), the current amplitude
and density were extend. However, there were no If current in groups A
andB. Comparedwith the control group(GroupA), Tbx3,HCN4, Cx45were
signiﬁcantly up-regulated but Nkx2.5, Cx43 were down-regulated in
groups C and D. Whereas Nkx2.5 and Cx43 were up-regulated in group B.
CONCLUSIONS Our results suggest that EPCS can promote the dif-
ferentiation of mShox2 genetically modiﬁed cMSCs into pacemaker-
like cells, generating If current.
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Successful Treatment of a LQT8 Case with Mexiletine: 4 years of
experience
Guoliang Li,1 Xiaolin Xue,1 Wenqi Han,1 Chaofeng Sun,1 Ganxin Yan1,2,3
1Department of Cardiovascular Medicine, The First Afﬁliated Hospital,
Xi’an Jiaotong University College of Medicine; 2Department of
Cardiovascular Medicine, Lankenau Medical Center and Lankenau
Institute of Medical Research; 3Department of Cardiovascular
Medicine, Jefferson Medical College of Thomas Jefferson University
OBJECTIVES Timothy syndrome (TS), also known as LQT8, is caused
by dominant gain-of-function mutations in Cav1.2. Previously, we
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hibition of late sodium current (INa, L) in a 2.5 year-old Chinese girl
with the typical TS phenotype of syndactyly, QT prolongation, 2:1 AV
block (AVB) and T wave alternans (TWA) in 2012. This study aimed to
review our practices over the past three years and promote the current
therapeutic strategies in the TS management.
METHODS Mexiletine (12.5 mg/kg per day) was initiated when the
proband’s 12-lead ECG revealed QTc of 600 ms, 2:1 AVB and TWA. 12-
lead ECGs and Holter monitoring were obtained once per month
during the ﬁrst year. Afterwards, Holter monitoring was performed
once in every 3-4 months. The QT interval was measured on lead II or
V5. Heart rate–corrected QT (QTc) was calculated using Bazett formula
(QT/ORR). The QT/RR slope was calculated based on the Holter
results.
RESULTS During the ﬁrst two years of treatment of mexiletine at a
maintenance dose of 150 to 200 mg daily, her ECGs and the Holter
monitoring revealed no 2:1 AVB and TWA, blunted QT/RR relationship
and QTc in a range from 500 to 560 ms. During this period, the patient
successfully underwent two syndactyly repair surgeries although the
anesthesiologist reported occurrence of one episode of non-sustained
polymorphic ventricular tachycardia during her second operation. In
the past one year, this patient had two episodes of syncope or
“seizure” activities. In one longer episode, she happened to wear a
Holter which did not reveal any ventricular arrhythmias. Although
they were not correlated to her syncope, 2:1 AVB and TWA reap-
peared. Her mexiletine dose was then adjusted to 250 mg daily. Dose
increase in mexiletine abolished 2:1 AVB and TWA.
CONCLUSIONS Our experiences suggests that inhibition of INa, L by
mexiletineis a promising pharmacotherapeutic approach in reduction
of arrhythmic risks in TS. However, mexiletine appears to lose its
efﬁcacy slowly with time.
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Meta-analysis of the HAS-BLED score for predicting major bleeding risk in
anticoagulated patients with atrial ﬁbrillation
Wengen Zhu,1 Kui Hong1,2
1Cardiology Department, the Second Afﬁliated Hospital of Nanchang
University, Jiangxi, 330006, China; 2Jiangxi Key Laboratory of
Molecular Medicine, Jiangxi, 330006, China
OBJECTIVES Three validated HAS-BLED, HEMORR2HAGES and
ATRIA bleeding scores, or even the CHADS2 and CHA2DS2-VASc stroke
scores, could be used to evaluate atrial ﬁbrillation(AF) patients’ major
bleeding risk. These scores have been validated in the various inde-
pendent studies. We therefore compared the diagnostic accuracy of
the HAS-BLED score to that of other risk scores in anticoagulated
patients with AF.
METHODS We systematically searched the Cochrane Library, Med-
line, PubMed and Embase databases for studies of the comparative
diagnostic performance between the HAS-BLED score and any of the
HEMORR2HAGES, ATRIA, CHADS2 or CHA2DS2-VASc scores. Data were
extracted from applicable studies, and then analyzed using statistical
methods such as the discrimination, calibration, net reclassiﬁcation
improvement(NRI) and integrated discrimination improvement(IDI)
analysis. The primary endpoints of AF patients were also deﬁned
dichotomously and compared between scores <3 and 3 for the HAS-
BLED score.
RESULTS 11 studies were identiﬁed for meta-analysis. We performed
the discrimination analysis by means of C-statistic with 95%
conﬁdence interval(CI). The pooled C-statistics respectively are
0.65(0.61-0.69) for HAS-BLED, 0.63(0.61-0.66) for HEMORR2HAGES,
0.63(0.56-0.72) for ATRIA, 0.55(0.49-0.61) for CHADS2 and 0.56(0.53-
0.59) for CHA2DS2-VASc. The HAS-BLED score demonstrates no sig-
niﬁcant differences of C-statistic for major bleeding risk prediction
when compared to the ATRIA or HEMORR2HAGES bleeding scores, but
gets the opposite results when compared to the CHADS2 or CHA2DS2-
VASc stroke scores. These results are further supported by the sig-
niﬁcant positive NRI and IDI values. Calibration analysis indicates the
HAS-BLED score over-predicts the risk of bleeding in the low
(RR¼1.16,95%CI 0.63-2.13;P¼0.64) risk stratiﬁcation, but under-pre-
dicts the risk of bleeding in the moderate (RR¼0.66,95%CI 0.51-
0.86;P¼0.002) and high (RR¼0.88,95%CI 0.70-1.10; P¼0.27) risk
stratiﬁcations. There are no signiﬁcant differences between the pre-
dicted and the observed major bleeding events in the low and high
risk stratiﬁcations. With regard to the occurrence of major bleeding
events individually, patients with HAS-BLED scores 3 have a greater
risk of major bleeding(RR¼2.97,95%CI, 2.32–3.80;P<0.00001) than
patients with HAS-BLED scores <3. A chi-squared test for trend showsan increasing trend in the occurrence of major bleeding events across
three risk stratiﬁcations according to the HAS-BLED score(c2¼108.57,
Ptrend<0.001).
CONCLUSIONS The HAS-BLED score not only performs better than
the HEMORR2HAGES and ATRIA bleeding scores, but also is superior
to the CHADS2and CHA2DS2-VASc stroke scores for bleeding predic-
tion. The HAS-BLED score should be the optimal choice to assess
major bleeding risk in clinical practice.
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Left Atrial Pressure Predicts Atrial Fibrillation Recurrence after Catheter
Ablation
Xiaobo Liao, Yanzong Yang, Lianjun Gao, Yunlong Xia, Dong Chang,
Xiaomeng Yin, Yingxue Dong, Xiaohong Yu, Xianjie Xiao,
Shulong Zhang
Arrhythmia Department of First Afﬁliated Hospital of Dalian Medical
University, Dalian Liaoning, 116011
OBJECTIVES An elevated left atrial pressure (LAP), a sign of atrial
structural remodeling, has been reported as a mechanism of atrial
ﬁbrillation (AF). However, the effect of LAP on the recurrence after AF
catheter ablation has not been well elucidated. We aimed to address
the predictive value of LAP and observe the inﬂuence for prognosis.
METHODS 150 patients of AF who underwent a ﬁrst-time catheter
ablation in our hospital were enrolled in the present study. Including
paroxysmal AF (n¼66) and persistent AF (n¼84). All patients under-
went transseptal puncture during procedure. LAP were measured
during sinus rhythm. According to the values of LAP, the patients
were divided into each two groups, high LAP ofparoxysmal AF group
(HP-PAF) and low LAP of paroxysmal AF group (LP-PAF), high LAP of
persistent AF group (HP-PeAF) and low LAP of persistent AF group
(LP-PeAF). The relationship between LAP and clinical variables were
analyzed. Recurrence rates of the each two groups were evaluated
through follow-up. Cox-regression analysis was implemented to ﬁnd
out the independent determinants of AF/AT recurrence after FRCA.
RESULTS (1) 150 AF patients were successfully followed up in the
study. Following up (10.24.9) months, 17 patients (51.5%) in HP-PAF
group and 29 patients (87.9%) in LP-PAF group maintained sinus after
RFCA (P<0.01). 15 patients (33.3%) in HP-PeAF group and 33 patients
(84.6%) in LP-PeAF group maintained sinus rhythm after RFCA
(P<0.01).
(2) For paroxysmal AF, LVEF (linear regression coefﬁcient B¼-0.761,
P¼0.002) was a good noninvasive parameter independently associ-
ated with LAP. For persistent AF, duration of AF(B¼0.826, P<0.001),
CHADS2-VASc score(B¼2.327, P<0.001), LAVI(B¼0.424, P<0.001 ),
IVS(B¼2.847, P<0.001), E/e’ (B¼-3.330, P<0.001), LVEF(B¼-0.651,
P<0.001) were good noninvasive parameters independently associ-
ated with LAP-PeAF.
(3) For paroxysmal AF, Cox-regression analysis revealed that LAP
(OR 1.27; 95%CI: 1.11-1.45; P<0.01) was the independent predictor of
AF/AT recurrence after FRCA. The area under ROC curve of LAP was
0.626. The cutoff point was 16.75mmHg (sensitivity 76.2%, speciﬁcity
82.2%). For persistent AF, LAP (OR 1.56;95%CI: 1.11-1.82; P¼0.019) was
also the independent predictor of AF/AT recurrence after FRCA. The
area under ROC curve of LAP was 0.836. The cutoff points were
17.3mmHg (sensitivity 83.3%, speciﬁcity 88.9%). In addition, duration
of AF, the antero-posterioratrial diameter of left atrium and LVEF
were also the independent predictors of AF/AT recurrence after FRCA.
And the predictive value of LAP was higher than that of others.
CONCLUSIONS (1) Elevated LAP was closely associated with
anatomical remodeling of the left atrium and was an independent
predictor for clinical recurrence after AF ablation.
(2) For paroxysmal AF, LVEF was a good noninvasive parameter
independently associated with LAP. For persistent AF, duration of AF,
CHADS2-VASc score, LAVI, IVS E/e’, LVEF were good noninvasive
parameters independently associated with LAP-PeAF.
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Study on Coronary Vein Anatomy of Patients with Dilated Heart
Cuijun Hao, Xiuchun Yang, Jingchao Lu, Fan Liu
The Second Hospital of Hebei Medical University
OBJECTIVES We will analyze the coronary venous system anatomy
through coronary vein direct enhancement and inverse develop-
ment. The conclusion will be used to conﬁrm electrophysiological
examination, radio frequency ablation, implantation of a LV lead and
so on.
